Introduction
============

Atrial fibrillation (AF) is the most common type of arrhythmia worldwide. It is the result of structural and/or electrophysiological abnormalities that produce abnormal impulse formation. An estimated 33.5 million individuals had AF by the year 2010.[@b1-ijgm-12-071] While more epidemiological studies on AF were carried out in developed countries, the rate of prevalence and incidence is steadily increasing worldwide. The prevalence in the USA, Europe, and New Zealand was 2.3%, 2%, and 1.7%, respectively.[@b2-ijgm-12-071]--[@b4-ijgm-12-071] In Saudi Arabia, only two hospital-based studies showed dissimilarities in the main causes of AF, whereas it has been attributed to the increasing aging population in the West.[@b5-ijgm-12-071],[@b6-ijgm-12-071] The implications of AF represent a great burden in terms of morbidity and mortality due to thromboembolic complications and heart failure (HF) as well as a wider healthcare and economic burden.[@b1-ijgm-12-071] AF is a multifactorial condition. The risks of developing AF can be associated with demographic factors, lifestyle factors, cardiovascular conditions, and comorbid conditions/procedures.[@b7-ijgm-12-071] The prevalence of AF increases with age; \~70% of cases of AF are in patients between 65 and 85 years of age.[@b8-ijgm-12-071] Male gender is associated with a 1.5-fold increased risk of developing AF.[@b9-ijgm-12-071] Risk of AF is also increased with low socioeconomic status.[@b10-ijgm-12-071]Alcohol consumers and current or former smokers are at greater risk of developing AF,[@b11-ijgm-12-071],[@b12-ijgm-12-071] and obesity (body mass index \[BMI\] ≥30 kg/m^2^) and high BMI are also associated with AF.[@b7-ijgm-12-071] In Saudi Arabia, hypertension (HTN) and diabetes are the most common risk factors for AF.[@b6-ijgm-12-071] Valvular heart disease, especially mitral valve disease, is another risk factor for AF observed particularly in developing countries.[@b13-ijgm-12-071] The likelihood of AF increases with structural heart disease. It is estimated that \>70% of patients with AF have cardiac disease, such as ischemic heart disease, myocarditis, pericarditis, cardiomyopathy, and hypertensive heart disease; congestive HF as AF is found in 30%--40% of patients with HF.[@b13-ijgm-12-071],[@b14-ijgm-12-071] Other comorbid diseases included are as follows: obstructive sleep apnea (OSA), chronic kidney disease (CKD), and pulmonary disease.[@b7-ijgm-12-071] Thyroid dysfunction, especially hyperthyroidism, has also been linked to AF.[@b15-ijgm-12-071]

By identifying the common risk factors and etiologies of AF related to the community, it will be possible to better detect and screen high-risk populations to prevent future complications of AF, such as stroke and thromboembolic attacks. Thus, this research aims to study the general characteristics of AF patients at King Abdulaziz University Hospital (KAUH), Jeddah, Saudi Arabia and identify the common comorbidities and risk factors associated with these patients. Moreover, the study aims to examine how AF patients who have valvular heart disease, HF, or diabetes mellitus (DM) differ from those who do not.

Patients and methods
====================

In reporting the methods of the study, the Strengthening the Reporting of Observational Studies in Epidemiology guidelines were followed.

Study design
------------

A retrospective study was conducted to assess the common risk factors and their prevalence in patients diagnosed with AF.

Setting
-------

The study was conducted in KAUH from 2010 to 2017. KAUH is a teaching tertiary center located in Jeddah, Saudi Arabia.

Participants
------------

A total of 167 patients were included in the study, representing all patients diagnosed with AF from 2010 to 2017 in KAUH. The diagnosis of AF was based on electrocardiogram findings and cardiologist experience.

Data sources and variables
--------------------------

Data were collected by utilizing both electronic - and paper-based medical records of patients diagnosed with AF. Information obtained from the medical records was collected on a structured form that included: demographic information, adverse lifestyle (smoking and obesity), and comorbidities. Patients' comorbidities included: HTN, ischemic heart disease, valvular heart disease, rheumatic heart disease, type 2 (T2DM), hyperthyroidism, OSA, CKD, rheumatoid arthritis (RA), and HF.

Bias
----

In order to minimize selection bias, all patients diagnosed with AF in the time period of the study were included.

Statistical methods
-------------------

Categorical variables were presented as frequencies and percentages. Continuous variables were presented as the mean ± SD. Patients were divided according to the presence and absence of valvular disease, HF, and T2DM. Comparison of these groups was carried out using the chi-squared test (for categorical variables) and independent samples *t*-test (for continuous variables). The level of significance was presented as *P*-values in different tables. All the required data for the current study were carefully collected, which resulted in no missing data, hence, missing data management was not required. The analysis was performed at a 5% level of significance using the SPSS, version 23 (IBM, Armonk, NY, USA). Data analysis was performed using SPSS, version 21 (SPSS Inc., Chicago, IL, USA). All *P*-values\<0.05 are considered statistically significant.

Ethical approval
----------------

This study was approved by the Unit of Biomedical Ethics Research Committee at King Abdulaziz University, and it was conducted in accordance with the Declaration of Hel-sinki. Patient consent to review their medical records was not required by the ethics committee. This waiver was due to the retrospective chart review nature of our study. No personal data that could reveal a patient entity were used. Patient data were strictly protected for confidentiality when conducting this study.

Results
=======

A total of 167 patients with AF were included in this study, of whom 72 (43.1%) were males. The mean ± SD age and BMI of all patients were 63.35±16.07 years and 28.83±7.67 kg/m^2^, respectively. More than half (58.7%) of the patients were non-Saudi nationals ([Table 1](#t1-ijgm-12-071){ref-type="table"}). The most prevalent risk factor among all patients was systemic HTN, present in 73.1%, followed by valvular disease (58.7%) and T2DM (53.3%). OSA (2.4%) and RA (3.0%) were among the least prevalent medical conditions.

The mean age difference between valvular (66.50±14.49 years) and nonvalvular (58.87±17.20 years) heart disease patients was statistically significant (*P*=0.002). The study also identified that coronary artery disease (CAD) was statistically more prevalent among valvular disease patients compared with their counterparts (*P*=0.001). Comparison of other variables of interest between valvular vs nonvalvular disease patients was statistically insignificant ([Table 2](#t2-ijgm-12-071){ref-type="table"}).

All the AF patients were split and compared according to the presence or absence of HF. Systemic HTN (*P*=0.005), CAD (*P*\<0.001), and CKD (*P*=0.003) were significantly more prevalent among the patients with HF compared with the rest of the patients. Comparison between all other characteristics was not statistically significant ([Table 3](#t3-ijgm-12-071){ref-type="table"}).

Because of the notable high prevalence of DM among the studied samples, the patients were compared according to presence or absence of T2DM. The results revealed the mean ± SD age of the former patients (69.25±12.66 years) was significantly greater than the mean ± SD age of the latter patients (56.62±16.95 years) (*P*\<0.001). A higher percentage of male AF patients had insulin-dependent DM compared with females (*P*=0.009). T2DM patients also had a higher chance of having HTN (*P*\<0.001) and CAD (*P*\<0.001) compared with patients with no T2DM ([Table 4](#t4-ijgm-12-071){ref-type="table"}).

Discussion
==========

In the present study, 167 patients with AF were recruited over a 7-year period based on the medical records of KAUH in Jeddah, Saudi Arabia. The mean age of the studied patients (63.35 years) matched the common age of developing AF identified in the literature. AF is common in the elderly population and is rare in \<50 years of age.[@b16-ijgm-12-071] Many mechanisms have been postulated for the correlation between the pathophysiology of aging and the development of AF. Some authors have hypothesized that the electrophysiological changes and the elevated resting membrane potential are the main pathophysiological mechanisms driving the abnormal intracellular calcium handling and the subsequent development of arrhythmia.[@b17-ijgm-12-071] Others have attributed the high prevalence of AF among the elderly to the reduction in atrial remodeling and the activation of oxidative cellular damage with the accumulation of ROS.[@b18-ijgm-12-071] The mean BMI of the studied patients in this research was 28.83. In agreement with previous research, obesity appears to be a risk factor for AF is Saudi Arabia.[@b15-ijgm-12-071],[@b19-ijgm-12-071] Obesity was reported to have negative consequences on cardiac structure, circulatory hemodynamics, and myocardial remodeling leading to a higher prevalence of AF among obese patients.[@b20-ijgm-12-071] In agreement with our results, Balaghi-Inalou et al, in their cross-sectional study on 120 patients with AF from Iran, reported that AF was common among elderly patients aged \>60 years.[@b21-ijgm-12-071]

With regard to gender, the results of the present study differed slightly from the literature. While AF is often reported to be prevalent among males, more than half of the recruited patients in this study were female.[@b22-ijgm-12-071] However, the present study had a higher number of patients with valvular than with nonvalvular heart disease; and, when the gender difference among AF patients with valvular and nonvalvular heart disease was compared, it was found that females were more likely to have AF with valvular heart disease, whereas both genders had a similar risk of developing AF with nonvalvular heart diseases. These different characteristics may be the reason for the different results. Gender is known to be associated with significant differences among patients with AF.[@b23-ijgm-12-071] Hormonal factors were proposed to play a major role; and the estrogen--progesterone fluctuation throughout the menstrual cycle was shown to have an impact on QT intervals. Females with AF have been reported to have more complications (especially cerebrovascular stroke and bleeding risk) and poorer outcomes than males.[@b24-ijgm-12-071],[@b25-ijgm-12-071] In the present study, female gender was significantly associated with DM on regression analysis compared with males (OR=0.4, *P*=0.009). No difference between the two genders was found with regard to HF risk (*P*=0.088). In agreement with these results, a review by Ko et al[@b26-ijgm-12-071] reported that HF rates were not significantly different between males and females with AF. However, the reverse was reported by O'Neal et al;[@b27-ijgm-12-071] in their research, females with AF had higher rates of hospitalization due to HF than males with the disease.

Upon reviewing the risk factors for AF in KAUH, it was found that HTN was the most prevalent risk factor encountered in approximately three quarters of the recruited patients (73.1%). The next most prevalent risk factors were valvular heart disease and T2DM, each occurring in more than half of the patients. Coronary heart disease, CKD, and smoking were less common, and few patients had RA, or OSA. HTN is a well-established risk factor for AF. It is estimated that one in every six cases of AF is caused by HTN.[@b28-ijgm-12-071] The mechanisms by which HTN can increase the risk of AF include left ventricular hypertrophy, diastolic dysfunction, and arterial atherosclerosis, which subsequently lead to atrial fibrosis and arrhythmia development.[@b29-ijgm-12-071] Furthermore, HTN increases the likelihood of other risk factors of AF, such as coronary heart disease, HF, and CKD.[@b30-ijgm-12-071] In the present study, regression analysis showed that HTN was significantly correlated with HF and DM. HTN not only causes AF, but also increases the risk of AF complications, particularly HF and embolic cerebrovascular stroke.[@b31-ijgm-12-071] In this study, hypertensive patients with AF were at three times more risk of developing HF than nonhypertensive patients (*P*\<0.005) and four times more likely to have comorbid T2DM (*P*\<0.001). Closely similar to our findings were the results reported by Balaghi-Inalou et al in Iran where HTN, congestive HF, and DM were prevalent among 78.3%, 38.8%, and 36.7%, respectively.[@b21-ijgm-12-071]

Valvular heart disease was more prevalent among patients with AF at KAUH than nonvalvular heart disease. Furthermore, valvular heart disease was significantly associated with old age and chronic heart disease when compared with nonvalvular disease. Patients with valvular heart disease tended to be 7 years older than patients with nonvalvular heart disease (66.5 vs 58.8 years). This is similar to what is reported in the literature: that valvular heart disease becomes more symptomatic and more severe with advanced age, with the highest prevalence in \>80 years of age.[@b32-ijgm-12-071] Higher prevalence of valvular heart disease among females may be related to the higher rheumatic and autoimmune etiologies of valvular heart disease, which are more common among females; in addition, coronary heart disease is a common risk factor and complication of AF.[@b33-ijgm-12-071],[@b34-ijgm-12-071]

HF is not an uncommon complication of AF. The present study investigated the risk factors for HF among the studied patients with AF; CKD, coronary heart disease, and HTN were the only significantly correlated variables. CKD was found to be the greatest risk factor for HF. CKD was more prevalent among patients with AF and HF than in patients with AF and no HF. The correlation between CKD and HF have long been studied. Both conditions have similar risk factors and their co-occurrence is reported to be associated with poor outcome.[@b35-ijgm-12-071] HF leads to accelerated atherosclerosis and reduction of blood flow to the kidney, leading to progressive damage to renal parenchyma and, consequently, CKD.[@b36-ijgm-12-071] CAD was the second most powerful variable associated with HF (*P*\<0.001). HF increased the risk of coronary heart disease in the studied patients most likely via similar mechanisms of reduced blood flow and accelerated atherosclerosis.[@b37-ijgm-12-071] There was also a significant association between HTN and HF among the studied patients (*P*=0.05). HTN results in progressive thickening of the left ventricle to compensate for the elevated pressure. Over time, the compensatory mechanisms fail and a transition from left ventricular hypertrophy to left ventricular dilatation and failure takes place.[@b30-ijgm-12-071]

The present study has the advantage that the data used were collected from 7 years worth of patients in a tertiary center that accepts patients of different nationalities. Data were collected utilizing the hospital's electronic system, which resulted in no missing data. The main limitation of the present study is that the electronic system was introduced in the hospital in 2010, so data from before that time were not readily available. In addition, this study did not include data about the different types of AF and how they behave differently, due to lack of relevant documentation.
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###### 

Baseline characteristics of all patients (n=167)

  Characteristics             N (%)
  --------------------------- -------------
                              
  Age (years) (mean ± SD)     63.35±16.07
  **Gender**                  
  Male                        72 (43.1)
  Female                      95 (56.9)
  **Nationality**             
  Saudi                       69 (41.3)
  Non-Saudi                   98 (58.7)
  BMI (kg/m^2^) (mean ± SD)   28.83±7.67

**Abbreviation:** BMI, body mass index.

###### 

Comparison of baseline characteristics, medical conditions, and cardiac risk factors between patients having valvular disease and not having valvular disease (n=167)

  Characteristics             Attributes   Yes N (%) (n=98)   No N (%)(n=69)   *P*-value
  --------------------------- ------------ ------------------ ---------------- -----------
                                                                               
  Age (years) (mean ± SD)                  66.50±14.49        58.87±17.20      0.002
  Gender                      Male         39 (39.8)          33 (47.8)        .302
  Female                      59 (60.2)    36 (52.2)                           
  Nationality                 Saudi        34 (34.7)          35 (50.7)        0.038
  Non-Saudi                   64 (65.3)    34 (49.3)                           
  BMI (kg/m^2^) (mean ± SD)                28.61±8.02         29.14±7.23       0.672
  Smoking                     Yes          11 (11.2)          7 (10.1)         0.825
  No                          87 (88.8)    62 (89.9)                           
  HTN                         Yes          75 (76.5)          47 (68.1)        0.227
  No                          23 (23.5)    22 (31.9)                           
  CAD                         Yes          52 (53.1)          18 (26.1)        0.001
  No                          46 (46.9)    51 (73.9)                           
  RHD                         Yes          6 (6.1)            2 (2.9)          0.337
  No                          92 (93.9)    67 (97.1)                           
  T2DM                        Yes          54 (55.1)          35 (50.7)        0.312
  No                          44 (44.9)    34 (49.3)                           
  Hyperthyroidism             Yes          3 (3.1)            5 (7.2)          0.212
  No                          95 (96.9)    64 (92.8)                           
  OSA                         Yes          2 (2.0)            2 (2.9)          0.721
  No                          96 (98.0)    67 (97.1)                           
  CKD                         Yes          19 (19.4)          6 (8.7)          0.057
  No                          79 (80.6)    63 (91.3)                           
  RA                          Yes          2 (2.0)            3 (4.3)          0.067
  No                          96 (98.0)    66 (95.7)                           

**Abbreviations:** BMI, body mass index; HTN, hypertension; CAD, coronary artery disease; HTN, hypertension; T2DM, type 2 diabetes mellitus; RA, rheumatoid arthritis; RHD, rheumatic heart disease; CKD, chronic kidney disease; OSA, obstructive sleep apnea.

###### 

Comparison of baseline characteristics, medical conditions, and cardiac risk factors between patients with heart failure and with no heart failure (n=167)

  Characteristics             Attributes   Yes N (%) (n=62)   No N (%) (n=105)   *P*-value
  --------------------------- ------------ ------------------ ------------------ -----------
                                                                                 
  Age (years) (mean ± SD)                  66.50±13.30        61.49±17.29        0.051
  Gender                      Male         32 (51.6)          40 (38.1)          0.088
  Female                      30 (48.4)    65 (61.9)                             
  Nationality                 Saudi        21 (33.9)          48 (45.7)          0.133
  Non-Saudi                   41 (66.1)    57 (54.3)                             
  BMI (kg/m^2^) (mean ± SD)                28.84±6.63         28.83±8.30         0.995
  Valvular disease            Yes          41 (66.1)          57 (54.3)          0.133
  No                          21 (33.9)    48 (45.7)                             
  Smoking                     Yes          10 (16.1)          8 (7.6)            0.087
  No                          52 (83.9)    97 (92.4)                             
  HTN                         Yes          53 (85.5)          69 (65.7)          0.005
  No                          9 (14.5)     36 (34.3)                             
  CAD                         Yes          37 (59.7)          33 (31.4)          \<0.001
  No                          25 (40.3)    72 (68.6)                             
  RHD                         Yes          3 (4.8)            5 (4.8)            0.982
  No                          59 (95.2)    100 (95.2)                            
  T2DM                        Yes          37 (59.7)          52 (49.5)          0.204
  No                          25 (40.3)    53 (50.5)                             
  Hyperthyroidism             Yes          4 (6.5)            4 (3.8)            0.440
  No                          58 (93.5)    101 (96.2)                            
  OSA                         Yes          3 (4.8)            1 (1.0)            0.113
  No                          59 (95.2)    104 (99.0)                            
  CKD                         Yes          16 (25.8)          9 (8.6)            0.003
  No                          46 (74.2)    96 (91.4)                             
  RA                          Yes          1 (1.6)            4 (3.8)            0.421
  No                          61 (98.4)    101 (96.2)                            

**Abbreviations:** BMI, body mass index; HTN, hypertension; CAD, coronary artery disease; HTN, hypertension; T2DM, type 2 diabetes mellitus; RA, rheumatoid arthritis; RHD, rheumatic heart disease; CKD, chronic kidney disease; OSA, obstructive sleep apnea.

###### 

Comparison of baseline characteristics, medical conditions, and cardiac risk factors between patients with T2DM and with no T2DM (n=167)

  Characteristics             Attributes   Yes N (%) (n=89)   No N (%) (n=78)   *P*-value
  --------------------------- ------------ ------------------ ----------------- -----------
                                                                                
  Age (years) (mean ± SD)                  69.25±12.66        56.62±16.95       \<0.001
  Gender                      Male         30 (33.7)          42 (53.8)         0.009
  Female                      59 (66.3)    36 (46.2)                            
  Nationality                 Saudi        34 (38.2)          35 (44.9)         0.383
  Non-Saudi                   55 (61.8)    43 (55.1)                            
  BMI (kg/m^2^) (mean ± SD)                29.62±7.29         27.92±8.05        0.169
  Valvular disease            Yes          54 (60.7)          44 (56.4)         0.577
  No                          35 (39.3)    34 (43.6)                            
  Smoking                     Yes          10 (11.2)          8 (10.3)          0.839
  No                          79 (88.8)    70 (89.7)                            
  HTN                         Yes          76 (85.4)          46 (59.0)         \<0.001
  No                          13 (14.6)    32 (41.0)                            
  CAD                         Yes          50 (56.2)          20 (25.6)         \<0.001
  No                          39 (43.8)    58 (74.4)                            
  RHD                         Yes          3 (3.4)            5 (6.4)           0.359
  No                          86 (96.6)    73 (93.6)                            
  Hyperthyroidism             Yes          5 (5.6)            3 (3.8)           0.593
  No                          84 (94.4)    75 (96.2)                            
  OSA                         Yes          3 (3.4)            1 (1.3)           0.378
  No                          86 (96.6)    77 (98.7)                            
  CKD                         Yes          16 (18.0)          9 (11.5)          0.245
  No                          73 (82.0)    69 (88.5)                            
  RA                          Yes          3 (3.4)            2 (2.6)           0.760
  No                          86 (96.6)    76 (97.4)                            
  Heart failure               Yes          37 (41.6)          25 (32.1)         0.204
  No                          52 (58.4)    53 (67.9)                            

**Abbreviations:** BMI, body mass index; HTN, hypertension; CAD, coronary artery disease; HTN, hypertension; T2DM, type 2 diabetes mellitus; RA, rheumatoid arthritis; RHD, rheumatic heart disease; CKD, chronic kidney disease; OSA, obstructive sleep apnea.
